vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $9.00 thousand in sales this quarter. This is the same as the same period last year.
$150M Crypto Shorts Liquidated In 12 Hours As Bitcoin Holds Near $25K
Crypto shorts took a severe hit as Bitcoin (CRYPTO: BTC) breached $26,000 early on Wednesday morning.
